![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 47, 37271-37277, November 24, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
, and
**
From the
Department of Life Science, Faculty of
Science, Himeji Institute of Technology, 3-2-1 Koto, Kamigori,
Hyogo 678-1297, the ¶ Department of Pediatrics, Gifu University
School of Medicine, 40 Tsukasa-Machi, Gifu 500-8076, and the
Department of Biological Chemistry, Faculty of Pharmaceutical
Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani,
Toyama 930-0194, Japan
Received for publication, July 18, 2000, and in revised form, August 18, 2000
| |
ABSTRACT |
|---|
|
|
|---|
We established a Chinese hamster ovary cell line
having a temperature-sensitive phenotype in peroxisome biogenesis. This
mutant (65TS) was produced by transforming a PEX2-defective
mutant, Z65, with a mutant PEX2 gene,
PEX2E55K, derived from a patient with infantile
Refsum disease, a milder form of peroxisome biogenesis disorder.
In 65TS, catalase was found in the cytosol at a nonpermissive
temperature (39 °C), but upon the shift to a permissive temperature
(33 °C), catalase gradually localized to the structures
containing a 70-kDa peroxisomal membrane protein, PMP70. In contrast to
catalase, other matrix proteins containing typical peroxisome targeting
signals, acyl-CoA oxidase and peroxisomal 3-ketoacyl-CoA thiolase, were
co-localized with PMP70 in most cells, even at 39 °C. We found that
these structures are partially functional peroxisomes and named them
"catalase-less peroxisomes." Catalase-less peroxisomes were also
observed in human fibroblasts from patients with milder forms of
peroxisome biogenesis disorder, including the one from which the mutant
PEX2 gene was derived. We suggest that these structures are
the causes of the milder phenotypes of the patients.
Temperature-dependent restoration of the peroxisomes in
65TS occurred even in the presence of cycloheximide, a protein
synthesis inhibitor. Thus, we conclude that in 65TS, catalase-less
peroxisomes are the direct precursors of peroxisomes.
Peroxisomes are present in a wide variety of eukaryotic cells,
from yeast to human (1). Peroxisomes commonly contain catalase and at
least one enzyme that generates hydrogen peroxide. The roles of
mammalian peroxisomes include oxidative processes involving H2O2, More than 20 genes named PEX (2) have been shown to be
involved in peroxisome assembly processes, based on the functional complementation of genetically peroxisome-deficient mutants of mammalian cells and yeasts (3). Peroxisomes have been thought to be
formed by the division of preexisting peroxisomes following the import
of newly synthesized peroxisomal proteins (4), but recent observations
suggest that endoplasmic reticulum may be involved in the peroxisomal
membrane biogenesis at least in certain yeast species (5, 6; for
review, see Ref. 7). Thus, questions are again being raised about the
intracellular origin of peroxisomes.
Peroxisome biogenesis disorders
(PBDs)1 are caused by
abnormalities in the assembly processes of peroxisomes. In many
PEX mutant cells, including the fibroblasts from PBD
patients, abnormal membrane structures called peroxisomal ghosts are
observed (8, 9). These structures contain a 70-kDa peroxisomal membrane
protein (PMP70) but lack the peroxisomal matrix proteins. PBDs
are genetically classified into at least 12 complementation groups
(CGs) (10), and each CG contains various clinical phenotypes,
e.g. Zellweger syndrome (ZS), neonatal
adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD). ZS
represents the severest form of PBD, NALD is the next severest, and IRD
is the mildest (11). These diseases differ markedly in clinical
features, such as age of death and severity of the neurological abnormalities.
In the fibroblasts of PBD patients with milder forms, temperature
sensitivity was observed in peroxisome assembly, and heterozygous mutations (E55K/R119Stop) were identified in the PEX2 genes
of an IRD fibroblast line of CG-F (12). Temperature-sensitive
(TS) mutations were further identified in PEX1 (13)
as well as PEX13 (14). The TS mutant cells seem to be useful
tools for investigating the mechanisms of peroxisome biogenesis,
because the peroxisome recovery process can be turned on simply by
shifting the culture temperature. Accordingly, we established a stable
Chinese hamster ovary (CHO) cell transformant with
PEX2E55K (65TS) on the background of a
PEX2-defective mutant, Z65 (15). In 65TS, peroxisomes formed
temperature-dependently. We now report that in 65TS the
peroxisomal ghosts indeed are partially functional "catalase-less
peroxisomes." Similar structures were also observed in the
fibroblasts from several patients with milder forms of PBD, including
the original IRD fibroblast line of CG-F. We suggest that catalase-less
peroxisomes are the cause of the milder phenotypes of these patients.
In addition, we present evidence that peroxisomes are formed from the
catalase-less peroxisomes in 65TS upon temperature shift-down.
Establishment of the TS Model Cells--
The human
PEX2E55K cDNA subcloned in the expression
vector pUcD2SR Cell Culture--
Cells were cultured in Ham's F-12
medium supplemented with 10% fetal calf serum. The fibroblasts from
PBD patients were maintained at 37 °C in 5% CO2, and TS
CHO mutant cells were maintained at 39 °C in 5% CO2.
For the analysis of temperature-dependent peroxisome restoration, temperature pairs of 37/30 °C and 39/33 °C were used for human fibroblasts and CHO cells, respectively. Higher temperatures were used for the CHO-derived cells, because they grew much faster at
33 °C than 30 °C and exhibited clearer TS phenotypes at 39 °C
than at 37 °C.
Immunofluorescence Studies--
Peroxisomes of CHO cells and
human fibroblasts were visualized by indirect immunofluorescence
staining, as described (20). The first antibodies used were rabbit
antibodies to rat catalase (from Dr. N. Usuda), rat AOX, rat
peroxisomal 3-ketoacyl-CoA thiolase (PT), and human catalase (each from
Dr. T. Hashimoto), and rat PMP70 or guinea pig antibodies to rat
PMP70 and catalase. The anti-PMP70 antibodies were prepared using the
carboxyl-terminal 15-residue peptide of the protein as an antigen (21).
The antigen-antibody complexes were detected with fluorescein
isothiocyanate- or Cy3-labeled goat antibody to rabbit IgG or
Cy3-labeled donkey antibody to guinea pig IgG.
Radiolabeling of Cells--
Cells were cultured in Ham's
F-12 medium supplemented with 10% fetal calf serum for 2 days
at selected temperatures. The medium was changed to Dulbecco's
modified Eagle's medium containing proline but lacking cysteine and
methionine and supplemented with dialyzed fetal calf serum at 10%.
After incubation for 24 h at each temperature with 100 µCi/ml
[35S]methionine/[35S]cysteine mixture
(PerkinElmer Life Sciences), cells were lysed and subjected to
immunoprecipitation with specific rabbit antibodies to rat AOX,
catalase, and PMP70. Immunocomplexes were recovered with fixed
Staphylococcus aureus cells (Zysorbin, Zymed
Laboratories Inc.) and analyzed by SDS-polyacrylamide gel
electrophoresis followed by autoradiography, as described (22). For the
experiment on the effect of cycloheximide, the drug was added at
varying concentrations to the medium 1 h before the addition of
radioactive amino acids, and the radioisotope was allowed to be
incorporated for 24 h at 33 °C.
Isolation and Characterization of the TS CHO Mutant--
We
previously showed that an IRD patient with CG-F PBD carried
heterozygous mutations in the PEX2 gene, E55K and R119Stop (12) (Fig. 1A), and the former
was responsible for the TS phenotype of the patient's cells in
peroxisome assembly. We isolated a temperature-sensitive CHO mutant,
65TS, by introducing the E55K mutant PEX2 gene into the
PEX2-defective CHO mutant, Z65 (15). Z65 itself
exhibited a punctate distribution of catalase at neither 33 °C (Fig.
1B, a) nor 39 °C (data not shown), although
PMP70 exhibited a punctate staining pattern, representing the ghosts
(Fig. 1B, b). In 65TS, catalase was found in the
cytosol at 39 °C (Fig. 1B, c), whereas PMP70
had a particulate distribution (Fig. 1B, d). When
65TS was incubated at 33 °C for 48 h, however, catalase was
co-localized with PMP70 in almost all the cells (Fig. 1B,
e and f). We pursued the time course of
peroxisome recovery in 65TS (Fig. 2).
After 3 h of incubation at 33 °C, we observed some cells
containing a few punctates of catalase. After 6 h, we could
identify in many cells catalase-positive granules that were also
positive for PMP70 (data not shown). Most cells contained
catalase-positive granules after 24 h of incubation at 33 °C,
and virtually all cells had peroxisomes by 48 h. Thus, it took at
least 3 to 6 h for the recovery of peroxisomes in 65TS, and the
process was completed within 48 h.
With respect to the peroxisome assembly, 65TS shuttled between the
phenotypes similar to the wild-type CHO and Z65, depending on the
temperatures. Fibroblasts from a TS patient belonging to CG-F (F-05)
lack the peroxisomes, like the fibroblasts from ZS patients at
37 °C, but when incubated at 30 °C, the F-05 fibroblasts regain
the peroxisomes to the same level as those of the normal fibroblasts
(12). Thus, the phenotypes of 65TS seemed similar to those of the
fibroblasts from the TS patient and would be useful for studying the
mechanism of peroxisome biogenesis and molecular defects of TS PBDs.
Proteins Carrying Typical PTSs Are Localized to Peroxisome-like
Structures at the Nonpermissive Temperature--
Using GFP-SKL
carrying a typical PTS-1 at the carboxyl end, we tried to
visualize the peroxisomes in living 65TS cells. Interestingly, the
stable transformant expressing GFP-SKL, named 65TS-TSKL, revealed a
punctate GFP distribution consistent with that of PMP70 at 39 °C
(Fig. 3, a and b)
as well as at 33 °C (Fig. 3, c and d). This was in contrast to the cytosolic distribution of catalase at 39 °C
(Fig. 3, e and f). Catalase exhibited punctate
staining superimposable with the GFP-SKL distribution in 65TS-TSKL at
33 °C (Fig. 3, g and h). Even at the
permissive temperature, however, the punctate distribution of catalase
and expression of GFP-SKL were complementary to each other,
i.e. catalase-positive particles were only observed in the
cells weakly expressing GFP-SKL (see Fig. 3 legend). On the
other hand, we observed that AOX and PT, having a typical PTS-1 and
PTS-2, respectively, were colocalized with GFP-SKL to particulate
structures at 39 °C (data not shown). Catalase has a variant PTS-1,
KANL, at the carboxyl terminus. Thus, we reasoned that the proteins
carrying typical PTSs would be translocated to the peroxisome-like
structures more easily than catalase. Typical PTS proteins but not
catalase would be translocated at 39 °C, and the former would be
more efficiently imported to peroxisomes than the latter at
33 °C.
Catalase-less Peroxisomes in 65TS Cells at the Nonpermissive
Temperature
We examined whether these peroxisome-like structures had normal
biochemical functions of peroxisomes, based on several criteria. We
first inspected whether AOX was correctly processed in these structures
by a radiolabeling experiment, as described (22). For 65TS incubated at
33 °C, processing of AOX (proteolytic conversion of the component A
to components B and C (18), although component C was hardly detected
under these conditions) was observed to the same extent as in the
wild-type CHO (Fig. 4B). Comparable amounts of the enzyme
(the sum of components A and B) were recovered from 65TS and the
wild-type CHO; these amounts were significantly larger than that
from Z65, reflecting the stabilization of the enzyme by segregation
into peroxisomes. It was indeed shown (15) that AOX is highly unstable
in Z65 and stabilized upon complementation by the normal
PEX2 gene. These results indicate that normal peroxisomes were formed in 65TS by shifting the temperature to 33 °C. Even at
39 °C, the total amounts of components A and B were comparable in
65TS and the wild-type CHO and were much larger than in Z65. This suggested that, even at 39 °C, AOX was segregated into
peroxisomes or peroxisome-like structures in 65TS to an extent close to
that in the wild-type CHO. A less efficient but considerable level of
processing was observed in 65TS at 39 °C (Fig. 4B,
lane 3), suggesting a partial functionality of the
processing system at this temperature. The poorer processing would not
affect the enzymatic function of AOX, because it is known that the
unprocessed recombinant AOX expressed in Escherichia coli is
fully active (23).
To further evaluate the metabolic functions of these peroxisome-like
structures, the Catalase-less Peroxisomes in Human PBD
Fibroblasts--
Catalase-less peroxisomes were also found in the IRD
fibroblast line of CG-F that originally carried the
PEX2E55K mutation (Fig.
5). Although catalase exhibited only
diffuse cytosolic staining, both AOX and PT did exhibit a punctate
distribution in many cells at 37 °C. The punctate pattern was more
prominent and found in a higher percentage of cells (more than 70% of
the total) with anti-PT antibody than with anti-AOX antibody,
indicating an efficient translocation of PT in this IRD cell line. AOX,
PT, and catalase were all cytosolic in the ZS cells of CG-F (F-01) (data not shown). It should be noted that the VLCFA
Catalase has usually been used as the definitive marker to discriminate
normal peroxisomes from nonfunctional peroxisomal ghosts. The presence
of catalase-less peroxisomes in an IRD patient of CG-F (F-05) raised
the question whether patients with milder forms of PBD generally have
hitherto overlooked similar structures. Accordingly, we examined this
possibility with the fibroblasts from an NALD patient of CG-C
(C-11)2 and an NALD and IRD
patient of CG-E (E-13 and E-24, respectively; see Ref. 13). The
responsible genes of CG-C and CG-E are PEX6 (16, 25, 26) and
PEX1 (27-29), respectively, both coding for the members of
the AAA-ATPase family. Interaction between these two peroxins was shown
(30-32), and hence it would seem reasonable that a defect in either of
them would result in similar phenotypes. In addition, a TS mutation
(G843D) has been identified in the PEX1 gene of patient E-24
(13). When these fibroblasts were cultured at 37 °C, catalase was
found in the cytosol, without a punctate pattern of distribution (Fig.
6). On the other hand, AOX and PT
exhibited punctate staining in around 80% of cells (Fig. 6), although
the signals were weaker, and the number of particles in each cell was
smaller than in normal cells (data not shown). These particles were
mostly superimposable with those of PMP70 and hence regarded as
peroxisome-related structures, although some particles seemed to be
irregular protein aggregates not overlapping with PMP70 signals. Heavy
abnormal aggregations of AOX and PT were observed in a considerable
number of cells, especially for C-11 and E-13 (data not shown). All
cells contained many PMP70-positive particles. A considerable number of
these particles were negative or below the detection limit for the
staining of AOX or PT. Thus, the import of AOX and PT in these mutant
cells seemed less efficient than that in normal cells. We observed no such particulate staining of AOX in ZS cells of the same CGs, although
weak particulate signals of PT were found in a small number of cells
(data not shown). Hence, we conclude that the cells of milder PBD
phenotypes contain catalase-less peroxisomes for at least CGs C, E, and
F, albeit at lower levels of matrix protein accumulation in
these structures.
Peroxisomes Are Formed from the Catalase-less Peroxisomes in 65TS
Cells--
In 65TS cells, peroxisomes were formed
temperature-dependently. To examine whether peroxisomes were
restored from the preexisting catalase-less peroxisomes by the import
of catalase from the cytosol, we investigated whether the recovery
process was inhibited by cycloheximide, a protein synthesis inhibitor.
65TS cells cultured at 39 °C were further cultured for 24 h at
33 °C in the presence or absence of 10 µg/ml cycloheximide.
Immunostaining of catalase showed that the enzyme was colocalized with
PMP70 even in the presence of the drug (Fig.
7A, c and
d), although the PMP70-containing structures seemed to be
large in size and irregular in shape as compared with those of the
cells cultured without the drug (Fig. 7A, a and
b). By radiolabeling the cells, we confirmed that
this concentration of cycloheximide completely inhibited the synthesis of catalase and PMP70 (Fig. 7, B and C). Total
protein synthesis also virtually ceased at this concentration of the
drug (Fig. 7D), and the incorporation of radioactivity into
trichloroacetic acid-insoluble materials decreased by 97% under
these conditions (data not shown).
These results suggest that the cytosolically distributed catalase
became colocalized with the pre-accumulated PMP70 upon temperature shift, without requiring de novo protein synthesis. This
also means that pre-accumulated mutant Pex2p is converted from a less active to an active form upon temperature shift, which in turn supports
the translocation of catalase. Hence, we conclude that peroxisomes are
derived from the catalase-less peroxisomes in 65TS. These results well
conform to the notion that peroxisomes are formed from the ghosts by
functional complementation of the peroxisome-deficient mutant cells
(33). In addition, these results support the hypothesis that
peroxisomes can develop by incorporating the newly synthesized
peroxisomal proteins from the cytosol.
The present results indicate that transfer of the
PEX2E55K gene into the PEX2-defective
CHO mutant, Z65, transmitted the TS phenotype observed in the F-05 IRD
fibroblasts. In the resulting CHO line, 65TS, catalase was found in the
cytosol at 39 °C, but its distribution became peroxisomal upon
shift-down to 33 °C. On the other hand, AOX and PT carrying a
typical PTS-1 and PTS-2, respectively, exhibited a peroxisomal
distribution in many cells, even at 39 °C. Although catalase seems
to be translocated by the PTS-1 pathway, its KANL peptide sequence at
the carboxyl terminus deviates from the consensus (34). Therefore, the
complex of catalase and Pex5p, the PTS-1 receptor, is possibly formed
with lower efficiency than complexes of typical PTS-1 proteins.
This would make the steady state concentration of catalase-Pex5p too
low to be captured by the peroxisomal import machinery containing the
TS Pex2p, at the nonpermissive temperature. The effect of poorer
recognition by the receptor is accentuated when catalase must compete
with an excess amount of a typical PTS-1 protein (Fig. 3, g
and h). In this situation, catalase is not translocated to
peroxisomes to a significant extent even at 33 °C. Proteins carrying
typical PTSs, however, form high steady state concentrations of the
complexes with the receptors, high enough to be recognized even by the
less active import machinery at the nonpermissive temperature.
The restoration of catalase import at the permissive temperature
clearly depends on the transition of the mutant Pex2p from the less
active (or inactive) state to the (more) active state, because the
process was not inhibited by cycloheximide. The mutant Pex2p would be
integrated into the membrane of the catalase-less peroxisomes normally
even at the nonpermissive temperature, thus supporting the import of
typical PTS proteins and, upon temperature shift-down, the import of
catalase. It is reasonable to suspect that the mutant Pex2p is in an
equilibrium between the two states at any temperature. Thus, at
39 °C, the total activity of the import machinery involving the
mutant Pex2p would be insufficient to support the translocation of
catalase but nearly sufficient to take up typical PTS proteins, whereas
the activity would reach a level high enough to allow the catalase
import at 33 °C. To verify this notion, we expressed the
PEX2E55K gene at a lower level by putting the
gene under the control of the basal promoter of the herpes simplex
virus thymidine kinase gene. This resulted in incomplete import of AOX
and PT at 39 °C and poor catalase import even at 33 °C (data not
shown). Thus, the import efficiencies of individual peroxisomal matrix
proteins depend on a delicate balance between the intrinsic intensities of the individual import signals and the net activity of the
peroxisomal import machinery.
The peroxisome-like structures observed in 65TS cells at 39 °C,
which contain AOX and PT but not catalase, indeed are nearly functional
catalase-less peroxisomes (Table I and Fig. 4B). AOX was
equally stable at 39 °C as in the wild-type CHO cells, probably reflecting the effective segregation into the peroxisomal lumen. The
processing of AOX, however, was less efficient, possibly because of
poorer assembly of the processing system. Catalase-less peroxisomes were also observed in the fibroblasts of PBD patients with milder phenotypes, belonging to three CGs: C, E, and F. The CG-F patient was
the original carrier of the PEX2E55K mutant
gene. In these cells, AOX and PT exhibited punctate patterns of
distribution overlapping with that of PMP70 at 37 °C, although the
staining intensities were weaker than those in 65TS. In the CG-F cells,
the VLCFA oxidation and DHAP-AT activities were higher than those of ZS
cells of the same CG, although much lower than the wild-type activities
(24, 35). Thus, the patient fibroblasts of CG-F and the 65TS model CHO
cells had similar TS phenotypes, but the functional defect at the
nonpermissive temperature was much more prominent in the former. This
was probably due to the weaker expression of the endogenous
PEX2 gene in the human fibroblasts than of the ectopic
PEX2 gene under the control of the viral expression system,
which was carried by 65TS. The present observations suggest that the
partially functional catalase-less peroxisomes would support the milder
phenotypes of NALD and IRD patients, at least in the cases studied.
Evaluation of peroxisomes of PBD patients based on immunofluorescent
microscopy should be done not only for catalase but also for typical
PTS proteins such as Import of catalase to the catalase-less peroxisomes at the permissive
temperature was not inhibited by cycloheximide, a protein synthesis
inhibitor. The most feasible interpretation of these results would be
that the catalase pre-accumulated in the cytosol directly enters the
preexisting catalase-less peroxisomes. The involvement of a vesicle
fusion process in peroxisome biogenesis was proposed, based on the
results of biochemical studies (36). It was also suggested that
catalase import occurs only to immature peroxisomes (or
precursor vesicles), not mature peroxisomes. Our results would be
compatible with this model if we suppose the involvement of recycling
membrane vesicles in the translocation of pre-accumulated catalase to
the catalase-less peroxisomes.
The present results are consistent with the result for the
PEX5 mutant CHO cells (33) that the restoration of
peroxisomes by the microinjection of Pex5p can occur in the presence of
cycloheximide and hence involves the translocation of the cytosolically
accumulated PTS proteins into the peroxisomal ghosts. Catalase-less
peroxisomes as well as peroxisomal ghosts are the structures that form
on the blockade of the normal course of peroxisome biogenesis because of a deficiency of one of the essential PEX gene products.
Thus, these structures reflect the processes of peroxisome biogenesis, even if they themselves do not represent the biogenesis
intermediates. They are ready to accept the PTS proteins if the correct
PEX gene products are supplied. The shapes and biochemical
compositions, however, may differ depending on the defective gene as
well as the severity of deficiency. The recovery processes also
probably differ depending on the defective genes. Moreover, net
formation of the peroxisomal membrane from a certain membrane seems
essential in the mutants defective in one of the three PEX
genes, PEX3, PEX16, and PEX19, because
these mutants lack peroxisomal ghosts but nevertheless are complemented
for peroxisome biogenesis by the transfer of respective genes (10,
37-41). Clues to the biochemical mechanism of peroxisome
biogenesis would be obtained by characterizing the processes of genetic
complementation of the respective PEX mutants.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-oxidation of fatty acids, and
biosynthesis of plasmalogens.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
MCS (16) was transfected to a
PEX2-deficient CHO cell mutant, Z65, by the calcium
phosphate method. Stable clones were selected by limiting dilution, by
culturing the transfectants for 6 days in the presence of 400 µg/ml
G418. One of the stable transformants revealed a punctate distribution
of catalase after 72 h of incubation at 30 °C but no
catalase-positive granules at 37 °C, like Z65. We named this clone
65TS. To visualize the peroxisomes in living 65TS cells, we produced a
transformant stably expressing green fluorescent protein
(GFP)-SKL. This fusion protein has the carboxyl-terminal 25 residues of
rat acyl-CoA oxidase (AOX) containing the Ser-Lys-Leu-COOH tripeptide
(a typical peroxisome targeting signal (PTS)-1) motif (17, 18) at the
carboxyl terminus of GFP(105). GFP(105) is a variant green fluorescent
protein having much improved fluorescence at higher temperatures (19).
An expression vector of GFP-SKL, pGFP-SKL, and pMiwhph, a vector
carrying a marker gene conferring hygromycin resistance, were
co-transfected to 65TS by the calcium phosphate method. Selection was
carried out by limiting dilution, by culturing the transfectants for 9 days in the presence of 400 units/ml hygromycin B, and then by
culturing for 5 days with both G418 and hygromycin B. A stable clone
with a punctate distribution of GFP at 30 °C was isolated and named
65TS-TSKL.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (81K):
[in a new window]
Fig. 1.
Establishment of TS CHO Mutant.
A, diagram of Pex2p primary structure and mutations found in
the patients. Patient F-01 was homozygous for the R119Stop mutation
(42), whereas F-05 was a heterozygote of E55K and R119Stop mutations
(12). Stippled boxes, hydrophobic regions;
shadowed box, Ring finger motif (15, 43). B,
immunofluorescent staining of catalase (a, c, and
e) and PMP70 (b, d, and f)
of mutant CHO cells. a and b, Z65;
c-f, 65TS. Cells were cultured at 33 °C (a
and b), 39 °C (c and d), and first
at 39 °C then at 33 °C for 48 h (e and
f). Each pair of pictures side by side represents the same
microscopic fields. The exposure time was automatically adjusted
according to the brightness of the objects. Hence, these pictures do
not necessarily accurately reflect the relative fluorescence
intensities. Bar, 20 µm.

View larger version (79K):
[in a new window]
Fig. 2.
Time course of peroxisome recovery in
65TS. The cells were first cultured at 39 °C and then kept for
the period indicated at 33 °C. Although only the immunostaining
patterns for catalase are shown, PMP70 staining was also carried out to
confirm the co-localization. Bar, 20 µm.

View larger version (84K):
[in a new window]
Fig. 3.
GFP-SKL is accumulated in peroxisome-like
structures in the TS cells even at 39 °C. Cells of the stable
transformant of 65TS with GFP-SKL, 65tsTSKL, were cultured at 39 °C
(a, b, e, and f) or
33 °C (c, d, g, and h).
The green fluorescence of GFP-SKL (a, c,
e, and g) was observed on the same field as that
for the immunostaining of PMP70 (b and d) and
catalase (f and h), with the Cy3-labeled second
antibody. Pairs of pictures of the same fields are presented side by
side. Bar, 10 µm. Note that all GFP-SKL transformant cells
did not express GFP-SKL efficiently, as particularly emphasized in
e and g. We usually observe such variable
expression of stably integrated ectopic genes among the cells derived
from a single clone, even when the cells are maintained in selection
media. This phenomenon is probably related to the stochastic
nature of the actions of gene enhancers to increase the probability but
not the level of gene expression (44). Thus, a substantial number of
the cells in a given population would not express the gene under
consideration, by chance.
--
We next examined the localization of the
peroxisomal matrix proteins in the original 65TS cells instead of
65TS-TSKL (Fig. 4A). When 65TS
cells were stained with anti-AOX or anti-PT antibody, punctate staining
overlapping with that of PMP70 was observed, even at 39 °C. In a
parallel experiment, we confirmed that catalase was diffusely
distributed in the cytosol at this temperature (data not shown). Thus,
the proteins having typical PTSs were indeed selectively translocated
to peroxisome-like structures at the nonpermissive temperature.
Catalase, on the other hand, was hardly imported to these structures
under the same conditions. This seems rather surprising, because
catalase has been used as a representative marker of peroxisomes.

View larger version (108K):
[in a new window]
Fig. 4.
Translocation of AOX and PT to
peroxisome-like structures in 65TS at 39 °C. A,
colocalization of AOX and PT with PMP70. 65TS cells were cultured at
39 °C and immunostained for AOX (a), PMP70 (b
and d), and PT (c). Pairs of pictures of the same
fields are presented side by side. Bar, 10 µm.
B, radiolabeling of AOX. Wild-type CHO (lanes 1 and 4), Z65 (lanes 2 and 5), and 65TS
(lanes 3 and 6) were radiolabeled with
[35S]methionine/cysteine for 24 h at 39 °C
(lanes 1-3) or 33 °C (lanes 4-6).
Radiolabeled AOX was immunoprecipitated, separated by
SDS-polyacrylamide gel electrophoresis, and detected by
autoradiography. The full-length polypeptide A and processing product B
are indicated by arrowheads. The smaller processing product
C was hardly detectable. A nonspecific faint band usually appears at
the same position as that of band B (15).
-oxidation capacity of very long chain fatty acid
(VLCFA) and peroxisomal dihydroxyacetone phosphate acyltransferase
(DHAP-AT) activity were measured (Table
I). 65TS incubated at both 30 and
37 °C exhibited significant VLCFA
-oxidation and peroxisomal
DHAP-AT activities, which were comparable with those of the wild-type
CHO. Note that these experiments were done at the 30/37 °C
temperature pair, because the experimental conditions had been
established at these temperatures. Thus, the biochemical activities of
the peroxisome-like structures observed in 65TS at higher temperatures
were normal with respect to these two parameters. Hence, we concluded
that these structures indeed were nearly functional peroxisomes, though
their functions seemed partial, because they lacked catalase and had
much lower processing activity of AOX. We named the structures
catalase-less peroxisomes.
Capacity of VLCFA
-oxidation and peroxisomal DHAP-AT activity
-oxidation
activities of palmitic (C16) and lignoceric (C24) acids were measured,
and the VLCFA
-oxidation capacity was represented by the ratio of
the activities against C24 and C16 fatty acids (45).
The activity of peroxisomal DHAP-AT was measured as described
(46) and expressed as nmol/2 h/mg protein. Two
independent experiments gave similar relativity among the activities of
different cell lines and at different temperatures, although the
absolute values varied. Result of a single experiment is shown.
-oxidation and
DHAP-AT activities of the same CG-F TS human fibroblasts as used in
this study (F-05) were considerably higher than those of the CG-F ZS
fibroblasts, even at 37 °C (24). Thus, the milder phenotypes of this
IRD patient are likely to have resulted from these catalase-less
peroxisomes, having partial biochemical functions at 37 °C. It
should be pointed out, however, that the functions of the catalase-less
peroxisomes of human fibroblasts were significantly reduced compared
with those of 65TS, with respect to these biochemical parameters.

View larger version (115K):
[in a new window]
Fig. 5.
Catalase-less peroxisomes of the fibroblasts
F-05. Cells were cultured at 37 °C and immunostained for
catalase (a), AOX (c), PT (e), and
PMP70 (b, d, and f). Pictures of the
same fields are presented side by side. Bar, 30 µm.

View larger version (53K):
[in a new window]
Fig. 6.
Catalase-less peroxisomes of the CG-C and
CG-E fibroblasts. NALD fibroblasts of CG-C (C-11; a-f)
and CG-E (E-13; g-l) and IRD fibroblasts of CG-E (E-24;
m-r) were cultured at 37 °C and immunostained for
catalase (a, g, and m), AOX
(c, i, and o), PT (e,
k, and q), and PMP70 (b, d,
f, h, j, l, n, p, and
r). Pairs of pictures presented side by side in the two rows
on the left, middle, and right represent the same fields.
Bar, 40 µm.

View larger version (79K):
[in a new window]
Fig. 7.
TS restoration of peroxisomes is not blocked
by cycloheximide. A, translocation of catalase to
catalase-less peroxisomes. 65TS cells were cultured first at 39 °C
and then for 24 h in the absence (a and b)
or presence (c and d) of 10 µg/ml cycloheximide
at 33 °C. Immunostaining was performed for catalase (a
and c) and PMP70 (b and d). Pictures
of the same fields are presented side by side. Bar, 10 µm.
B, C, and D, radiolabeling of PMP70,
catalase, and total proteins, respectively. 65TS cells were incubated
at 33 °C in the presence of
[35S]methionine/[35S]cysteine and
cycloheximide at the concentrations indicated (in µg/ml). Cells were
lysed with an equal amount of lysis solution, and equal amounts of
lysates were subjected to immunoprecipitation (B and
C) or analyzed directly by SDS-polyacrylamide gel
electrophoresis (D).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-oxidation enzymes.
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. F. Tokunaga for the help on protein radiolabeling experiments.
| |
FOOTNOTES |
|---|
* This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Present address: Kaken Pharmaceutical Co., 14 Shinomiya Minamikawara-cho, Yamashina-ku, Kyoto 607-8042, Japan.
** To whom correspondence should be addressed. Tel.: 81-791-58-0192; Fax:81-791-58-0193; E-mail: osumi@sci.himeji-tech.ac.jp.
Published, JBC Papers in Press, August 25, 2000, DOI 10.1074/jbc.M006347200
2 A. Imamura, N. Shimozawa, Y. Suzuki, and N. Kondo, unpublished result on the assignment of patient.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PBD, peroxisome biogenesis disorder; PMP70, 70-kDa peroxisomal membrane protein; CG, complementation group; ZS, Zellweger syndrome; NALD, neonatal adrenoleukodystrophy; IRD, infantile Refsum disease; TS, temperature-sensitive; CHO, Chinese hamster ovary; GFP, green fluorescent protein; AOX, acyl-CoA oxidase; PTS, peroxisome targeting signal; PT, peroxisomal 3-ketoacyl-CoA thiolase; VLCFA, very long chain fatty acid; DHAP-AT, peroxisomal dihydroxyacetone phosphate acyltransferase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Lazarow, P. B., and Fujiki, Y. (1985) Annu. Rev. Cell Biol. 1, 489-530 |
| 2. | Distel, B., Erdmann, R., Gould, S. J., Blobel, G., Crane, D. I., Cregg, J. M., Dodt, G., Fujiki, Y., Goodman, J. M., Just, W. W., Kiel, J. A., Kunau, W. H., Lazarow, P. B., Mannaerts, G. P., Moser, H. W., Osumi, T., Rachubinski, R. A., Roscher, A., Subramani, S., Tabak, H. F., Tsukamoto, T., Valle, D., van der Klei, I., van Veldhoven, P., and Veenhuis, M. (1996) J. Cell Biol. 135, 1-3 |
| 3. | Tabak, H. F., Braakman, I., and Distel, B. (1999) Trends Cell Biol. 9, 447-453 |
| 4. | Lazarow, P. B., Robbi, M., Fujiki, Y., and Wong, L. (1982) Ann. N. Y. Acad. Sci. 386, 285-300 |
| 5. | Elgersma, Y., Kwast, L., van den Berg, M., Snyder, W. B., Distel, B., Subramani, S., and Tabak, H. F. (1997) EMBO J. 16, 7326-7341 |
| 6. | Titorenko, V. I., and Rachubinski, R. A. (1998) Mol. Cell. Biol. 18, 2789-2803 |
| 7. | Kunau, W. H., and Erdmann, R. (1998) Curr. Biol. 8, R299-R302 |
| 8. | Santos, M. J., Imanaka, T., Shio, H., Small, G. M., and Lazarow, P. B. (1988) Science 239, 1536-1538 |
| 9. | Santos, M. J., Imanaka, T., Shio, H., and Lazarow, P. B. (1988) J. Biol. Chem. 263, 10502-10509 |
| 10. | Shimozawa, N., Suzuki, Y., Zhang, Z., Imamura, A., Kondo, N., Kinoshita, N., Fujiki, Y., Tsukamoto, T., Osumi, T., Imanaka, T., Orii, T., Beemer, F., Mooijer, P., Dekker, C., and Wanders, R. J. (1998) Am. J. Hum. Genet. 63, 1898-1903 |
| 11. | Lazarow, P. B., and Moser, H. W. (1995) in The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R. , Beaudet, A. L. , Sly, W. S. , and Valle, D., eds), 7th Ed. , pp. 2287-2324, McGraw-Hill Inc., New York |
| 12. | Imamura, A., Tsukamoto, T., Shimozawa, N., Suzuki, Y., Zhang, Z., Imanaka, T., Fujiki, Y., Orii, T., Kondo, N., and Osumi, T. (1998) Am. J. Hum. Genet. 62, 1539-1543 |
| 13. | Imamura, A., Tamura, S., Shimozawa, N., Suzuki, Y., Zhang, Z., Tsukamoto, T., Orii, T., Kondo, N., Osumi, T., and Fujiki, Y. (1998) Hum. Mol. Genet. 7, 2089-2094 |
| 14. | Shimozawa, N., Suzuki, Y., Zhang, Z., Imamura, A., Toyama, R., Mukai, S., Fujiki, Y., Tsukamoto, T., Osumi, T., Orii, T., Wanders, R. J., and Kondo, N. (1999) Hum. Mol. Genet. 8, 1077-1083 |
| 15. | Tsukamoto, T., Miura, S., and Fujiki, Y. (1991) Nature 350, 77-81 |
| 16. | Tsukamoto, T., Miura, S., Nakai, T., Yokota, S., Shimozawa, N., Suzuki, Y., Orii, T., Fujiki, Y., Sakai, F., Bogaki, A., Yasumo, H., and Osumi, T. (1995) Nat. Genet. 11, 395-401 |
| 17. | Miyazawa, S., Osumi, T., Hashimoto, T., Ohno, K., Miura, S., and Fujiki, Y. (1989) Mol. Cell. Biol. 9, 83-91 |
| 18. | Miyazawa, S., Hayashi, H., Hijikata, M., Ishii, N., Furuta, S., Kagamiyama, H., Osumi, T., and Hashimoto, T. (1987) J. Biol. Chem. 262, 8131-8137 |
| 19. | Yamasaki, M., Hashiguchi, N., Tsukamoto, T., and Osumi, T. (1998) Bioimages 6, 1-7 |
| 20. | Osumi, T., Tsukamoto, T., Hata, S., Yokota, S., Miura, S., Fujiki, Y., Hijikata, M., Miyazawa, S., and Hashimoto, T. (1991) Biochem. Biophys. Res. Commun. 181, 947-954 |
| 21. | Imanaka, T., Shiina, Y., Takano, T., Hashimoto, T., and Osumi, T. (1996) J. Biol. Chem. 271, 3706-3713 |
| 22. | Tsukamoto, T., Yokota, S., and Fujiki, Y. (1990) J. Cell Biol. 110, 651-660 |
| 23. | Setoyama, C., Tamaoki, H., Nishina, Y., Shiga, K., and Miura, R. (1995) Biochem. Biophys. Res. Commun. 217, 482-487 |
| 24. | Imamura, A., Shimozawa, N., Suzuki, Y., Zhang, Z., Tsukamoto, T., Fujiki, Y., Orii, T., Osumi, T., and Kondo, N. (2000) Brain Dev. 22, 8-12 |
| 25. | Fukuda, S., Shimozawa, N., Suzuki, Y., Zhang, Z., Tomatsu, S., Tsukamoto, T., Hashiguchi, N., Osumi, T., Masuno, M., Imaizumi, K., Kuroki, Y., Fujiki, Y., Orii, T., and Kondo, N. (1996) Am. J. Hum. Genet. 59, 1210-1220 |
| 26. | Yahraus, T., Braverman, N., Dodt, G., Kalish, J. E., Morrell, J. C., Moser, H. W., Valle, D., and Gould, S. J. (1996) EMBO J. 15, 2914-2923 |
| 27. | Portsteffen, H., Beyer, A., Becker, E., Epplen, C., Pawlak, A., Kunau, W. H., and Dodt, G. (1997) Nat. Genet. 17, 449-452 |
| 28. | Reuber, B. E., Germain-Lee, E., Collins, C. S., Morrell, J. C., Ameritunga, R., Moser, H. W., Valle, D., and Gould, S. J. (1997) Nat. Genet. 17, 445-448 |
| 29. | Tamura, S., Okumoto, K., Toyama, R., Shimozawa, N., Tsukamoto, T., Suzuki, Y., Osumi, T., Kondo, N., and Fujiki, Y. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 4350-4355 |
| 30. | Tamura, S., Shimozawa, N., Suzuki, Y., Tsukamoto, T., Osumi, T., and Fujiki, Y. (1998) Biochem. Biophys. Res. Commun. 245, 883-886 |
| 31. | Geisbrecht, B. V., Collins, C. S., Reuber, B. E., and Gould, S. J. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8630-8635 |
| 32. | Faber, K. N., Heyman, J. A., and Subramani, S. (1998) Mol. Cell. Biol. 18, 936-943 |
| 33. | Yamasaki, M., Hashiguchi, N., Fujiwara, C., Imanaka, T., Tsukamoto, T., and Osumi, T. (1999) J. Biol. Chem. 274, 35293-35296 |
| 34. | Purdue, P. E., and Lazarow, P. B. (1996) J. Cell Biol. 134, 849-862 |
| 35. | Shimozawa, N., Imamura, A., Zhang, Z., Suzuki, Y., Orii, T., Tsukamoto, T., Osumi, T., Fujiki, Y., Wanders, R. J., Besley, G., and Kondo, N. (1999) J. Med. Genet. 36, 779-781 |
| 36. | Titorenko, V. I., Chan, H., and Rachubinski, R. A. (2000) J. Cell Biol. 148, 29-44 |
| 37. | Hettema, E. H., Girzalsky, W., van den Berg, M., Erdmann, R., and Distel, B. (2000) EMBO J. 19, 223-233 |
| 38. | Honsho, M., Tamura, S., Shimozawa, N., Suzuki, Y., Kondo, N., and Fujiki, Y. (1998) Am. J. Hum. Genet. 63, 1622-1630 |
| 39. | South, S. T., and Gould, S. J. (1999) J. Cell Biol. 144, 255-266 |
| 40. | Kinoshita, N., Ghaedi, K., Shimozawa, N., Wanders, R. J. A., Matsuzono, Y., Imanaka, T., Okumoto, K., Suzuki, Y., Kondo, N., and Fujiki, Y. (1998) J. Biol. Chem. 273, 24122-24130 |
| 41. | Matsuzono, Y., Kinoshita, N., Tamura, S., Shimozawa, N., Hamasaki, M., Ghaedi, K., Wanders, R. J., Suzuki, Y., Kondo, N., and Fujiki, Y. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2116-2121 |
| 42. | Shimozawa, N., Tsukamoto, T., Suzuki, Y., Orii, T., Shirayoshi, Y., Mori, T., and Fujiki, Y. (1992) Science 255, 1132-1134 |
| 43. | Patarca, R., and Fletcher, M. A. (1992) FEBS Lett. 312, 1-2 |
| 44. | Fiering, S., Whitelaw, E., and Martin, D. I. (2000) Bioessays 22, 381-387 |
| 45. | Suzuki, Y., Shimozawa, N., Yajima, S., Yamaguchi, S., Orii, T., and Hashimoto, T. (1991) Biochem. Pharmacol. 41, 453-456 |
| 46. | Shimozawa, N., Suzuki, Y., Orii, T., Yokota, S., and Hashimoto, T. (1988) Pediatr. Res. 24, 723-727 |
This article has been cited by other articles:
![]() |
R. Ito, M. Morita, N. Takahashi, N. Shimozawa, N. Usuda, T. Imanaka, and M. Ito Identification of Pex5pM, and Retarded Maturation of 3-Ketoacyl-CoA Thiolase and Acyl-CoA Oxidase in CHO Cells Expressing Mutant Pex5p Isoforms J. Biochem., December 1, 2005; 138(6): 781 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Legakis, J. I. Koepke, C. Jedeszko, F. Barlaskar, L. J. Terlecky, H. J. Edwards, P. A. Walton, and S. R. Terlecky Peroxisome Senescence in Human Fibroblasts Mol. Biol. Cell, December 1, 2002; 13(12): 4243 - 4255. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guerra-Giraldez, L. Quijada, and C. E. Clayton Compartmentation of enzymes in a microbody, the glycosome, is essential in Trypanosoma brucei J. Cell Sci., January 7, 2002; 115(13): 2651 - 2658. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |